MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Posted on Mar 8, 2021, 10:35 pm
#21

I agree. Nuvasive is losing literally millions upon millions of dollars by not having Stryde on the market. They probably have their engineers on top of this as we speak. How long for it to return? Who knows. But, it couldn't that long. The technology is already developed and has demonstrated success in a large number of patients. It's simply a matter of tweaking a few things. Let me know your thoughts.

Like (0)
Posted on Mar 8, 2021, 11:29 pm
#22

Quote from: BreaktoGrow on March 08, 2021, 10:35:06 PMI agree. Nuvasive is losing literally millions upon millions of dollars by not having Stryde on the market. They probably have their engineers on top of this as we speak. How long for it to return? Who knows. But, it couldn't that long. The technology is already developed and has demonstrated success in a large number of patients. It's simply a matter of tweaking a few things. Let me know your thoughts.


End of this year you can anticipate with STRYDE. Before is optimism.

Like (0)
Posted on Mar 10, 2021, 2:26 pm
#23

I just talked to a representative of Nuvasive. There is no problem with Stryde. The reason it has stopped shipping is that a new regulation requires a study for biocompatibility and toxicity. They will finish this study within Q3 this year. Therefore it should definitely be available in Q4, I.e. October.
Other manufacturers would need to do the same. However whether they do it or not is another question.

Like (0)
Posted on Mar 10, 2021, 6:21 pm
#24

That's great news. Do you have the contact number for that representative? Thanks for sharing, by the way.

Like (0)
Posted on Mar 11, 2021, 7:02 am
#25

Quote from: hanshi on March 10, 2021, 02:26:01 PMI just talked to a representative of Nuvasive. There is no problem with Stryde. The reason it has stopped shipping is that a new regulation requires a study for biocompatibility and toxicity. They will finish this study within Q3 this year. Therefore it should definitely be available in Q4, I.e. October.
Other manufacturers would need to do the same. However whether they do it or not is another question.


Paley has announced that 60% of people have had odd bone formation possibly due to corrosion. How can you be sure there is no problem with Stryde?

Like (0)
Posted on Mar 11, 2021, 7:12 am
#26

Quote from: one on March 11, 2021, 07:02:41 AMPaley has announced that 60% of people have had odd bone formation possibly due to corrosion. How can you be sure there is no problem with Stryde?


If that.. is true...  that's a very serious concern...

Like (0)
Posted on Mar 14, 2021, 8:25 pm
#27

Quote from: PANDA:BEAR.. on March 11, 2021, 07:12:50 AMIf that.. is true...  that's a very serious concern...


Could "odd" be a problem though. I can only imagine if it was they would have brought up the issue then and not only now.

Like (0)
Posted on Mar 15, 2021, 5:30 pm
#28
Like (0)

You must be logged in to post a reply.

Related Topics